Two judgments handed down by the High Court and Court of
Appeal, respectively, in late 2023 helpfully summarise the current
scope of the Norwich Pharmacal jurisdiction in
Ireland.
In particular, the Court of Appeal took the opportunity to
review the development of the jurisdiction in Ireland and,
cognisant of the "significant debate (and attendant
uncertainty)", provided a very useful summary of the Irish
position, which differs to other common law jurisdictions.
While the Court of Appeal confirmed that Norwich Pharmacal
relief is exceptional, it deemed the test set out in Salesian
Secondary College [2021] IEHC 287 that the plaintiff must
establish "very clear proof" to be too high a barrier.
However, the Court of Appeal did not accept that the position in
Ireland was the same as that in England and Wales (i.e. that the
plaintiff must simply demonstrate a "good arguable case"
against the alleged wrongdoer) and instead confirmed that
appropriate test in Ireland